Results 91 to 100 of about 5,403 (175)

Radioimmunotherapy for Malignant Mesothelioma Targeting C-ERC/Mesothelin. [PDF]

Pharmaceuticals (Basel)
Hanaoka H, Yamaguchi A, Maeda M, Segawa T, Oriuchi N.   +4 more
europepmc   +1 more source

The central role of radiotherapy in remodeling the tumor immune microenvironment: mechanisms and therapeutic implications. [PDF]

Front Cell Dev Biol
Yi Z, Chen N, Jiang X, Hu X.
europepmc   +1 more source

Diselenide-bridged hybrid mesoporous silica for radiosensitization and radioprotection in the radioimmunotherapy of colorectal cancer. [PDF]

J Nanobiotechnology
Zhang F, Xie X, Lu J, Fang H, Ning Q, Wang J, Shan Y, Wang S, Zhao X, Chen F, Dong W, Chang Z, Li L.   +12 more
europepmc   +1 more source

DLL3-targeted immunoPET and radioimmunotherapy ligands. [PDF]

Am J Nucl Med Mol Imaging
Liang SH.
europepmc   +1 more source

Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming. [PDF]

Signal Transduct Target Ther
Zhou L, Liu Y, Xing Z, Wu Y, Yang X, Chen S, Kang K, Wang M, Zhou Z, Huang M, Gong Y, Zhou L, Zhou X, Li J, Yao Z, Zheng Q, Kong FS, Niedermann G, Luo R, Lu Y, Xue J.   +20 more
europepmc   +1 more source

Pharmacokinetic Optimization of Radiocopper-Based Theranostic Pretargeting. [PDF]

Mol Pharm
Cornejo MA, Samuels ZV, Dehlavi G, Carter L, Kao WM, Strugala E, Zeglis BM.   +6 more
europepmc   +1 more source

Outcomes and toxicity of concomitant radioimmunotherapy following PD-1 blockade for locally advanced and metastatic cutaneous squamous cell carcinoma. [PDF]

Front Oncol
Kassardjian AA, Ladbury CJ, Tam A, Maroongroge S, Xing Y, Muddasani R, Modi B, Amini A.   +7 more
europepmc   +1 more source

Assessment of pneumonitis in patients with lung cancer undergoing radioimmunotherapy and immune checkpoint inhibitor rechallenge. [PDF]

Commun Med (Lond)
Ruan Y, Ruan M, Fang Z, Sun Z, Zhuang K, Wu Z, Yu C, Liu Z, Wu D, Dong Z, Wei W.   +10 more
europepmc   +1 more source

²²⁵Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2-Expressing Breast Cancer. [PDF]

J Nucl Med
Rinne SS, Burnes Vargas D, Seo S, Veach D, McDevitt MR, Vaughn BA, Xu H, Guo HF, Fung EK, de Stanchina E, Miranda IC, Larson SM, Cheung NKV, Cheal SM.   +13 more
europepmc   +1 more source

Molecular mechanisms underlying the abscopal effect induced by radiotherapy and its synergistic translational potential with immunotherapy. [PDF]

Ther Adv Med Oncol
Chen X, Yang M, Huang Y, Tu J, Cai Y, Yuan X.   +5 more
europepmc   +1 more source